Kinomics accelarating biosensors

Deutsche Version >>
Home | Products | Literature | News | Contact | Imprint
News
Kinomics defined beneficial, unique add-ons for affinity-based biosensors.

Archive

Seasonal Greetings 2016 / 2017

Seasonal Greetings!

Collecting these cards?
It could be worth it in high resolution!


04/23/2015
Download of test license temporalily not available


Seasonal Greetings 2015 / 2016

Seasonal Greetings!

Collecting these cards?
It could be worth it in high resolution!


Seasonal Greetings 2014 / 2015

Seasonal Greetings!

Collecting these cards?
It could be worth it in high resolution!


Seasonal Greetings 2013 / 2014

Seasonal Greetings!

Collecting these cards?
It could be worth it in high resolution!


Seasonal Greetings 2012 / 2013

Seasonal Greetings!

Collecting these cards?
It could be worth it in high resolution!

Kinomics press release 2012/001

01/07/2012
Final settlement with GE Healthcare

Based on the issued MSK patents, see http://www.kinomics.com/produkte_msk_en.php?lid=2, especially reg the US patent # 7,824,924 ("Trutnau") issued Nov 2, 2010, GE Healthcare and Kinomics have entered a settlement agreement in Dec 2011, which finalizes the take-over of the MSK methodology rights agreed in June 2006. Financial details of the settlement were not disclosed.

"This settlement denotes the successful conclusion of a positive long-term collaboration of both companies", says Hans-H. Trutnau, Managing Director of Kinomics.

About Kinomics:

Kinomics GmbH was founded in November 2004 by Hans-H. Trutnau as a privately-held company. The Company is dedicated to offering innovative software solutions and consulting services in order to save time and material in biomolecular interaction analysis based on SPR-based biosensors. Hans-H. Trutnau has more than 17 years of sales, marketing, and development experience of such biosensors and has applied for several patents in this field.

Contact: info[a]kinomics.com


Seasonal Greetings 2011 / 2012

Seasonal Greetings!

Collecting these cards?
It could be worth it in high resolution!


Seasonal Greetings 2010 / 2011

Seasonal Greetings!

Collecting these cards?
It could be worth it in high resolution!

Kinomics press release 2010/001

12/20/2010
Multi-Step Kinetics (MSK) patents issued

After in the EU in 2006, the Kinomics MSK methodology is now also patent protected in the US. Actually, the according United States Patent # 7,824,924 ("Trutnau") was issued and published (www.uspto.gov).
"This is another step ahead in the success story of Kinomics", says Hans-H. Trutnau, Managing Director of Kinomics, and adds: "This step would have been impossible without GE Healthcare, the leading supplier of affinity-based biosensors. The users of Biacore® systems love this methodology!"

Users of Biacore systems can purchase MSK licenses from Kinomics; a test version is available free of charge via the Kinomics homepage.

About Kinomics:

Kinomics GmbH was founded in November 2004 by Hans-H. Trutnau as a privately-held company. The Company is dedicated to offering innovative software solutions and consulting services in order to save time and material in biomolecular interaction analysis based on SPR-based biosensors. Hans-H. Trutnau has more than 16 years of sales, marketing, and development experience of such biosensors and has applied for several patents in this field.

Contact: info[a]kinomics.com


Seasonal Greetings 2009 / 2010

Seasonal Greetings!

Collecting these cards?
It could be worth it in high resolution!


Kinomics press release 2009/002

11/25/2009
New Inhibition-in-Solution Assay from Kinomics


Right away with its 5th anniversary, Kinomics exclusively offers an important extension of its Multi-Step Kinetics (MSK) methodology, the "Inhibition-in-Solution Assay" via MSK.

For the first time ever, utilizing this assay, concentrations of reaction partners of an equilibrated inhibition reaction (i.e., in solution!) can be determined via extended MSK - and, hence, the inhibition constant of the reaction that was completed prior to the MSK analysis. "This is solely feasible in case that the consecutive MSK steps can be individually evaluated with regard to concentration-related parameters. With MSK and its decisive extension from Kinomics, this is exclusively facilitated - namely, in a simple and surprisingly intuitive manner", says Hans-H. Trutnau, founder and Managing Director of Kinomics GmbH.

Kinomics looks for Biacore users as cooperation partners who would like to test this new Inhibition-in-Solution Assay (ISA, patent pending)! An Application Note on the MSK ISA is available on the Kinomics homepage.

Users of Biacore systems can purchase MSK licenses from Kinomics; a test version is available free of charge via the Kinomics homepage.

About Kinomics:

Kinomics GmbH was founded in November 2004 by Hans-H. Trutnau as a privately-held company. The Company is dedicated to offering innovative software solutions and consulting services in order to save time and material in biomolecular interaction analysis based on SPR-based biosensors. Hans-H. Trutnau has more than 15 years of sales, marketing, and development experience of such biosensors and has applied for several patents in this field.

Contact: info[a]kinomics.com


Kinomics press release 2009/001

11/25/2009
Kinomics celebrates its 5th anniversary

Almost exactly five years ago, Kinomics GmbH was founded with the aim to establish time and material saving methodologies in affinity-based biosensorics.

"This has been successfully accomplished and had enduringly influenced the acceptance of the methodology", says Hans-H. Trutnau, founder and Managing Director of Kinomics GmbH; "biosensor applications that were thought to be virtually impossible for more than 10 years, are practically approved since then and today acknowledged as an alternative." As a result, the Multi-Step Kinetics (MSK) invented by Kinomics was taken over in an exclusive cooperation by Biacore AB (now part of GE Healthcare) in 2006 and, shortly after, marketed as Single-Cycle Kinetics (SCK), although much less flexible than MSK (what a comparative test may reveal). Users of Biacore systems can purchase MSK licenses from Kinomics; a test version is available free of charge via the Kinomics homepage.

Right away with the anniversary, Kinomics exclusively offers an interesting extension of the MSK methodology, the "Inhibition-in-Solution Assay". More details can be found in 'Topics' on the Kinomics homepage.

By accident or not - Mozilla's Firefox (the safer internet browser free of charge) celebrates now also its 5th anniversary.

About Kinomics:

Kinomics GmbH was founded in November 2004 by Hans-H. Trutnau as a privately-held company. The Company is dedicated to offering innovative software solutions and consulting services in order to save time and material in biomolecular interaction analysis based on SPR-based biosensors. Hans-H. Trutnau has more than 15 years of sales, marketing, and development experience of such biosensors and has applied for several patents in this field.

Contact: info[a]kinomics.com


Kinomics press release 2006/003

09/09/2006
Kinomics announces collaboration with Biacore

Kinomics GmbH, Germany, has agreed a long-term cooperation with Biacore AB, Sweden, now part of GE Healthcare, the leading provider of SPR-based systems for interaction analysis. As part of the collaboration, Biacore has purchased from Kinomics a family of patents that covers Multi-Step Kinetics (MSK). When used in combination with certain Biacore systems, MSK methodology speeds up and simplifies the measurement of the kinetic parameters of an interaction.
The agreement includes a grant-back from Biacore so that Kinomics can continue to offer its MSK software to Biacore users. Currently, an updated MSK software version 1.1 is available; see MSK product page for more details.

"This agreement represents a great added value for users of Biacore systems", says Hans-H. Trutnau, founder and Managing Director of Kinomics GmbH. "Kinomics is delighted to interact and cooperate in the future with the market leader of SPR-based biosensors. Many Biacore users can now benefit from an innovative approach in their day-to-day routine interaction analysis."

This agreement has been made at the same time as Kinomics relocates its operations to Eltville, bringing the company close to the international airport in Frankfurt. New contact details can be found in the imprint.

About Kinomics:

Kinomics GmbH was founded in November 2004 by Hans-H. Trutnau as a privately-held company. The Company is dedicated to offering innovative software solutions and consulting services in order to save time and material in biomolecular interaction analysis based on SPR-based biosensors. Hans-H. Trutnau has more than 12 years of sales, marketing, and development experience of such biosensors and has applied for several patents in this field.

About GE Healthcare:

GE Healthcare, a unit of General Electric Company (NYSE: GE), provides transformational medical technologies and services that are shaping a new age of patient care. GE Healthcare's expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, life sciences, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform and treat disease, so their patients can live their lives to the fullest.

Contact: info[a]kinomics.com


Kinomics press release 2006/002

04/06/2006
Three papers published on Kinomics' MSK® in biosensorics


Great success for Kinomics: Since early 2006, already three papers have been published that utilize Kinomics' patent-pending, time- and sample-saving Multi-Step-Kinetics (MSK®) principle of unnecessary intermediate regenerations in affinity-based biosensorics (the corresponding author is mentioned first):

Trutnau, H.-H. (2006) New multi-step kinetics using common affinity biosensors saves time and sample at full access to kinetics and concentration; J Biotechnol.; submitted 07/17/2005, published online 03/30/2006

Myszka, D.G. et al. (2006) Analyzing a kinetic titration series using affinity biosensors; Anal Biochem., 349, 136-147; submitted 08/15/2005, published 02/01/2006

Zeng, X. et al. (2006) Nonregeneration Protocol for Surface Plasmon Resonance: Study of High-Affinity Interaction with High-Density Biosensors; Anal Chem., 78, 1841-1848; submitted 10/18/2005, published 03/15/2006

"As announced earlier, these publications verify the enormously growing interest in the efficient Kinomics approach; the commercial MSK® software is characterized by its ease of use and numerously cross-checked results - something users simply must not miss in practice", said Hans-H. Trutnau, Managing Director of Kinomics GmbH.

About Kinomics:

Kinomics GmbH was founded by Hans-H. Trutnau in November 2004 as a privately held company and is dedicated to saving time and material in biomolecular interaction analysis by means of affinity biosensors.

MSK is a registered trademark of Kinomics GmbH.

Contact: info[a]kinomics.com


Kinomics press release 2006/001

01/10/2006
First submitted paper on MSK® in biosensorics accepted for publication!

The first submitted paper regarding the application of Multi-Step Kinetics (MSK®) in affinity biosensorics, submitted on July 17, 2005, has been accepted for publication by the Journal of Biotechnology on January 4, 2006 (see Literature, bottom of page). The work presents the basic differences and advantages of the MSK® approach (e.g., unnecessary regeneration) in comparison to the traditional way of data acquisition and evaluation. Especially, the detection and consideration of mass-transport limitations and the self-consistency of results are reflected. A practical example of a kinetics evaluation, employed in cooperation with the company Biaffin (www.biaffin.com), is a proof for the applicability with commercially available biosensors and for the significant savings in time and material by MSK®.
The patent-pending methodology is not restricted to a certain number of analyte injections, outlier injections can be easily omitted from evaluation, and the final kinetics results can be intuitively assessed by a traffic-light indicator (see Products, MSK®).
After print, the publication details will be updated in the literature list. Further publications, currently in preparation, will follow soon.
"This and other coming papers show the growing acceptance of the Kinomics approach due to the enormous benefits for the users. With MSK®, the expensive biosensor equipment can be utilized up to 10-fold more efficient", said Hans-H. Trutnau, Managing Director of Kinomics.

About Kinomics:

Kinomics GmbH was founded by Hans-H. Trutnau in November 2004 as a privately held company and is dedicated to saving time and material in biomolecular interaction analysis by means of affinity biosensors.

MSK is a registered trademark of Kinomics GmbH.

Contact: info[a]kinomics.com


Kinomics press release 2005/003

09/12/2005
Kinomics launches its new MSK® software for affinity biosensorics during BioTechnica - test it!

Kinomics GmbH (www.kinomics.com) announced today the launch of its new Multi-Step Kinetics (MSK®) software during the BioTechnica trade show (www.biotechnica.de, hall 2, booth A14) from Oct 18 to 20, 2005, in Hannover, Germany. MSK® can be applied with standard affinity biosensors (e.g., Biacore®) without hardware changes at massive savings in time and material since intermediate sensor chip regenerations, ligand re-captures (in capture assays), and titration equilibrations are unnecessary. Nonetheless, access to detailed and highly self-consistent kinetics constants is ensured.

Have a test on Kinomics: MSK® test data provided by biosensor users (visit this page for test procedure) will be live evaluated at the booth!

Kinomics offers attractive discounts for orders placed during BioTechnica - don't be late!

About Kinomics:

Kinomics GmbH was founded by Hans-H. Trutnau in November 2004 as a privately held company and is dedicated to saving time and material in biomolecular interaction analysis by means of affinity biosensors.

MSK is a registered trademark of Kinomics GmbH.
Biacore is a registered trademark of Biacore AB.

Contact: info[a]kinomics.com


Kinomics press release 2005/002

06/24/2005

Kinomics wins StartUp award in Lower Saxony, Germany!

Kinomics GmbH (www.kinomics.com) has been awarded as winner in Lower Saxony (federal state of Germany) of the StartUp businessplan contest 2005 (www.startup-initiative.de), being the best of 29 competitors (and within the best 25 of 503 competitors in total Germany). "This is a great verification of the Kinomics concept and has immediately opened new financial opportunities. Doubtlessly, the positive tests of the efficient Multi-Step Kinetics approach by our biosensor cooperation partners have contributed to this success", said Hans-H. Trutnau, Managing Director of Kinomics GmbH. The company plans to present its new MSK® software release on the BioTechnica trade show later this year in Hannover, Germany.

About Kinomics:

Kinomics GmbH was founded by Hans-H. Trutnau in November 2004 as a privately held company and is dedicated to saving time and material in biomolecular interaction analysis by means of affinity biosensors.

Kinomics  StartUp-Award Award celebration at the LzO bank (www.lzo.de) in Oldenburg, Germany; from left to right: Andreas Renken (LzO), Hans-H. Trutnau (Kinomics), Detmar Schlobohm (LzO)

enlarge picture (242 kB)


Kinomics press release 2005/001

03/10/2005
Kinomics GmbH on the launch!

From mid of March 2005, Kinomics GmbH is presented on its newly released web site (www.kinomics.com). Detailed information is available on how to accelerate measurements by means of affinity biosensors. Since more than 10 years, affinity biosensors are applied, e.g., in kinetics characterization of anti-cancer therapeutics. As a specific highlight of the Kinomics offer, the patent protected Multi-Step Kinetics approach (MSK®) permits up to 10-fold faster kinetics measurements with biosensors and, by means of novel cross-checks, an improved confidence (self-consistency) of the results. This indicates a major enhancement of the performance-to-price ratio of routinely applied affinity biosensors.

back

 

© Kinomics GmbH 2004-2017
Last updated: 01/22/2017
Topics
Since 12/31/2016, Kinomics GmbH is in Liquidation (i.L.). This process will be finalized at the end of 2017.